» Articles » PMID: 22194599

Decorin Antagonizes the Angiogenic Network: Concurrent Inhibition of Met, Hypoxia Inducible Factor 1α, Vascular Endothelial Growth Factor A, and Induction of Thrombospondin-1 and TIMP3

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2011 Dec 24
PMID 22194599
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Decorin, a small leucine-rich proteoglycan, inhibits tumor growth by antagonizing multiple receptor tyrosine kinases including EGFR and Met. Here, we investigated decorin during normoxic angiogenic signaling. An angiogenic PCR array revealed a profound decorin-evoked transcriptional inhibition of pro-angiogenic genes, such as HIF1A. Decorin evoked a reduction of hypoxia inducible factor (HIF)-1α and vascular endothelial growth factor A (VEGFA) in MDA-231 breast carcinoma cells expressing constitutively-active HIF-1α. Suppression of Met with decorin or siRNA evoked a similar reduction of VEGFA by attenuating downstream β-catenin signaling. These data establish a noncanonical role for β-catenin in regulating VEGFA expression. We found that exogenous decorin induced expression of thrombospondin-1 and TIMP3, two powerful angiostatic agents. In contrast, decorin suppressed both the expression and enzymatic activity of matrix metalloprotease (MMP)-9 and MMP-2, two pro-angiogenic proteases. Our data establish a novel duality for decorin as a suppressor of tumor angiogenesis under normoxia by simultaneously down-regulating potent pro-angiogenic factors and inducing endogenous anti-angiogenic agents.

Citing Articles

Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype.

Buraschi S, Pascal G, Liberatore F, Iozzo R Proteoglycan Res. 2025; 3(1).

PMID: 40066261 PMC: 11893098. DOI: 10.1002/pgr2.70014.


Decorin-armed oncolytic adenovirus promotes natural killers (NKs) activation and infiltration to enhance NK therapy in CRC model.

Li X, Zhang Y, Mao Z, Zhao H, Cao H, Wang J Mol Biomed. 2024; 5(1):48.

PMID: 39482550 PMC: 11527862. DOI: 10.1186/s43556-024-00212-z.


Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy.

Mongiat M, Pascal G, Poletto E, Williams D, Iozzo R Proteoglycan Res. 2024; 2(3).

PMID: 39184370 PMC: 11340296. DOI: 10.1002/pgr2.22.


Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression.

Yen H, Liao W, Chen C, Su Y, Huang Y, Hsiao C Mol Oncol. 2024; 18(10):2569-2585.

PMID: 38770553 PMC: 11459036. DOI: 10.1002/1878-0261.13667.


Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.

Aljagthmi W, Alasmari M, Daghestani M, Al-Kharashi L, Al-Mohanna F, Aboussekhra A Cells. 2024; 13(8.

PMID: 38667295 PMC: 11049637. DOI: 10.3390/cells13080680.


References
1.
Weis S, Zimmerman S, Shah M, Covell J, Omens J, Ross Jr J . A role for decorin in the remodeling of myocardial infarction. Matrix Biol. 2005; 24(4):313-24. DOI: 10.1016/j.matbio.2005.05.003. View

2.
Iozzo R, Bolender R, Wight T . Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis. Lab Invest. 1982; 47(2):124-38. View

3.
Danielson K, Baribault H, Holmes D, Graham H, Kadler K, Iozzo R . Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997; 136(3):729-43. PMC: 2134287. DOI: 10.1083/jcb.136.3.729. View

4.
CSORDAS G, Santra M, Reed C, Eichstetter I, McQuillan D, Gross D . Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem. 2000; 275(42):32879-87. DOI: 10.1074/jbc.M005609200. View

5.
Okawa T, Michaylira C, Kalabis J, Stairs D, Nakagawa H, Andl C . The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev. 2007; 21(21):2788-803. PMC: 2045132. DOI: 10.1101/gad.1544507. View